Cargando…
Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case–control study
BACKGROUND: Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, patients suffering from primary adrenal insufficiency (AI) have an increased mortality, mainly due to cardiovascular diseases. Only little knowledge exists on the contribution of MC substitution to the c...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817592/ https://www.ncbi.nlm.nih.gov/pubmed/32488723 http://dx.doi.org/10.1007/s40618-020-01309-2 |
_version_ | 1783638672168452096 |
---|---|
author | Müller, M. Beiglböck, H. Fellinger, P. Winhofer, Y. Luger, A. Gschwandtner, M. Willfort-Ehringer, A. Koppensteiner, R. Kautzky-Willer, A. Krebs, M. Schlager, O. Wolf, P. |
author_facet | Müller, M. Beiglböck, H. Fellinger, P. Winhofer, Y. Luger, A. Gschwandtner, M. Willfort-Ehringer, A. Koppensteiner, R. Kautzky-Willer, A. Krebs, M. Schlager, O. Wolf, P. |
author_sort | Müller, M. |
collection | PubMed |
description | BACKGROUND: Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, patients suffering from primary adrenal insufficiency (AI) have an increased mortality, mainly due to cardiovascular diseases. Only little knowledge exists on the contribution of MC substitution to the cardiovascular risk. Therefore, this study investigates the impact of plasma renin concentration on parameters of micro- and macrovascular function. METHODS: 26 patients with primary AI [female = 18, age: 51 (28; 78) years; BMI: 24 (18; 40) kg/m(2); disease duration: 18 (5; 36) years] were included in this cross-sectional analysis. Intima media thickness (IMT) and pulse wave velocity (PWV) were investigated to assess macrovascular remodeling and arterial stiffness. Microvascular function was estimated by post-occlusive reactive hyperemia using laser Doppler fluxmetry. Baseline perfusion, biological zero, peak perfusion, time to peak and recovery time were recorded. Patients were grouped according to their median plasma renin concentration of previous visits (Renin(high) vs Renin(low)) and were compared to a group of healthy women [age: 44 (43; 46) years; BMI: 24.2 (21.8; 27.5)]. RESULTS: PWV was significantly higher in AI patients compared to controls [9.9 (5; 18.5) vs 7.3 (6.8; 7.7) m/s; p < .01], whereas no differences in microvascular function could be found. In Renin(low) time to peak perfusion was significantly longer [6.0 (3; 15) vs 3.5 (1.5; 11) s; p < .05], whereas no differences in IMT and PWV were observed between Renin(high) and Renin(low). No impact of GC dose was observed. CONCLUSIONS: Microvascular function is not impaired in patients with primary AI under adequate replacement therapy, although higher renin concentrations are associated with subclinical improvements. No relation between RAAS activity and macrovascular function is observed, while arterial stiffness might be increased in primary AI. |
format | Online Article Text |
id | pubmed-7817592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-78175922021-01-25 Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case–control study Müller, M. Beiglböck, H. Fellinger, P. Winhofer, Y. Luger, A. Gschwandtner, M. Willfort-Ehringer, A. Koppensteiner, R. Kautzky-Willer, A. Krebs, M. Schlager, O. Wolf, P. J Endocrinol Invest Original Article BACKGROUND: Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, patients suffering from primary adrenal insufficiency (AI) have an increased mortality, mainly due to cardiovascular diseases. Only little knowledge exists on the contribution of MC substitution to the cardiovascular risk. Therefore, this study investigates the impact of plasma renin concentration on parameters of micro- and macrovascular function. METHODS: 26 patients with primary AI [female = 18, age: 51 (28; 78) years; BMI: 24 (18; 40) kg/m(2); disease duration: 18 (5; 36) years] were included in this cross-sectional analysis. Intima media thickness (IMT) and pulse wave velocity (PWV) were investigated to assess macrovascular remodeling and arterial stiffness. Microvascular function was estimated by post-occlusive reactive hyperemia using laser Doppler fluxmetry. Baseline perfusion, biological zero, peak perfusion, time to peak and recovery time were recorded. Patients were grouped according to their median plasma renin concentration of previous visits (Renin(high) vs Renin(low)) and were compared to a group of healthy women [age: 44 (43; 46) years; BMI: 24.2 (21.8; 27.5)]. RESULTS: PWV was significantly higher in AI patients compared to controls [9.9 (5; 18.5) vs 7.3 (6.8; 7.7) m/s; p < .01], whereas no differences in microvascular function could be found. In Renin(low) time to peak perfusion was significantly longer [6.0 (3; 15) vs 3.5 (1.5; 11) s; p < .05], whereas no differences in IMT and PWV were observed between Renin(high) and Renin(low). No impact of GC dose was observed. CONCLUSIONS: Microvascular function is not impaired in patients with primary AI under adequate replacement therapy, although higher renin concentrations are associated with subclinical improvements. No relation between RAAS activity and macrovascular function is observed, while arterial stiffness might be increased in primary AI. Springer International Publishing 2020-06-01 2021 /pmc/articles/PMC7817592/ /pubmed/32488723 http://dx.doi.org/10.1007/s40618-020-01309-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Müller, M. Beiglböck, H. Fellinger, P. Winhofer, Y. Luger, A. Gschwandtner, M. Willfort-Ehringer, A. Koppensteiner, R. Kautzky-Willer, A. Krebs, M. Schlager, O. Wolf, P. Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case–control study |
title | Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case–control study |
title_full | Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case–control study |
title_fullStr | Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case–control study |
title_full_unstemmed | Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case–control study |
title_short | Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case–control study |
title_sort | micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case–control study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817592/ https://www.ncbi.nlm.nih.gov/pubmed/32488723 http://dx.doi.org/10.1007/s40618-020-01309-2 |
work_keys_str_mv | AT mullerm microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy AT beiglbockh microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy AT fellingerp microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy AT winhofery microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy AT lugera microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy AT gschwandtnerm microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy AT willfortehringera microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy AT koppensteinerr microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy AT kautzkywillera microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy AT krebsm microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy AT schlagero microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy AT wolfp microandmacrovascularfunctioninpatientssufferingfromprimaryadrenalinsufficiencyacrosssectionalcasecontrolstudy |